SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-031889
Filing Date
2008-05-09
Accepted
2008-05-09 16:20:44
Documents
6
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a08-13733_110q.htm 10-Q 734469
2 EX-31.1 a08-13733_1ex31d1.htm EX-31.1 16058
3 EX-31.2 a08-13733_1ex31d2.htm EX-31.2 15656
4 EX-32.1 a08-13733_1ex32d1.htm EX-32.1 6343
5 EX-32.2 a08-13733_1ex32d2.htm EX-32.2 6523
6 GRAPHIC g137331bai001.jpg GRAPHIC 3542
  Complete submission text file 0001104659-08-031889.txt   785574
Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 08818713
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1